Back to top
more

Basilea Pharmaceutica (BPMUF)

(Delayed Data from OTC)

$67.75 USD

67.75
NA

0.00 (0.00%)

Updated Jul 30, 2025 12:03 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 244)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Are Medical Stocks Lagging Basilea Pharmaceutica (BPMUF) This Year?

by Zacks Equity Research

Here is how Basilea Pharmaceutica AG (BPMUF) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

Zacks Equity Research

Best Momentum Stock to Buy for August 28th

by Zacks Equity Research

QFIN, CTRE and BPMUF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 28, 2024.

Zacks Equity Research

New Strong Buy Stocks for August 28th

by Zacks Equity Research

BPMUF, QFIN, CRNC, SN and PINE have been added to the Zacks Rank #1 (Strong Buy) List on August 28, 2024.

Zacks Equity Research

Recent Price Trend in Basilea Pharmaceutica (BPMUF) is Your Friend, Here's Why

by Zacks Equity Research

Basilea Pharmaceutica (BPMUF) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Equity Research

Is Basilea Pharmaceutica (BPMUF) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Basilea Pharmaceutica AG (BPMUF) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

Zacks Equity Research

Basilea Pharmaceutica (BPMUF) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Basilea Pharmaceutica (BPMUF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Equity Research

Here's Why Momentum in Basilea Pharmaceutica AG (BPMUF) Should Keep going

by Zacks Equity Research

Basilea Pharmaceutica AG (BPMUF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Is Basilea Pharmaceutica (BPMUF) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Basilea Pharmaceutica AG (BPMUF) and AVEO Pharmaceuticals (AVEO) have performed compared to their sector so far this year.

Zacks Equity Research

Here's What Could Help Basilea Pharmaceutica AG (BPMUF) Maintain Its Recent Price Strength

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Basilea Pharmaceutica AG (BPMUF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.